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In cultured vascular smooth muscle cells (VSMC) angiotensin 11 (ang II) indues tyrosin¢ and serine/thrconine phosphorylation a d activation of 
two mitogen-activated protein (MAP) kinases. When extracts ofang II-stimulated VSMC were fractionated by Mono Q anion-exchange column 
chromatography, three peaks of the activities which in vitro activate inactive MAP kinases were detected, These MAP kinas¢ activator activities 
were not detected in extracts of umtimulatcd VSMC, in vitro activation of MAP kinases by the MAP kinas¢ activators was accompanied bytyrosine 
and serine/threonin¢ phosphorylation f MAP kinasea. These results uggest that the MAP kinase activators are involved in the ang ll-indueed 
phosphorylation a d activation of MAP kinases in VSMC. 
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1. INTRODUCTION 
In cultured vascular smooth muscle cells (VSMC), 
angiotensin 1I (ang II) stimulates ribosomal protein $6 
kinase activity [1], protein synthesis [2], phosphoryla- 
tion of nuclear membrane lamins [3] and expression of 
the protooncogenes, c-fos and c-myc [4,5]. These ang 
II-induced events may be involved in the induction of 
hypertrophy ofVSMC, which is one of the fundamental 
pathogenetic features of hypertension [6], however° the 
molecular mechanisms by which ang I1 regulates these 
ribosomal and nuclear events have not been elucidated. 
Mitogen-activated protein (MAP) kinascs are mem- 
bers of a family of serine/threonine.specific protein ki- 
nases whose activation is commonly induced by a vari- 
ety of growth factors, such as insulin, epidermal growth 
factor (EGF) and platelet-derived growth factor [7-9]. 
These growth factors activate MAP kinases via phos- 
phorylation on both tyrosine and serine/threonine resi- 
dues [10,11]. MAP kinase thus activated phosphorylates 
and reactivates the phosphatase-inactivated S6 kinase 
II [12]. $6 kinase II has been shown to phosphorylate 
nuclear lamin C [13] in addition to ribosomal protein 
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$6. Moreover, it has recently been demonstrated that 
MAP kinascs phosphorylate he products of the pro- 
tooneogenes, c-jun, c-los and c-myc [14-16]. In a preced- 
ing report, we have shown that ang II induces tyrosine 
and serin¢/threonine phosphorylation a d activation of 
two MAP kinases in cultured VSMC [17]. Thus it is 
likely that MAP kinases play important roles as inter- 
mediates in the signalling pathways from the ang II 
receptors, as well as the growth factor receptors, to the 
ribosomes and nucleus. 
Recently, the MAP kinase activators or MAP kinase 
kinases, which in vitro stimulate tyrosine and serine/ 
threonine phosphorylation a d activation of MAP ki- 
nases, were found in EGF-stimulated fibroblasts and 
nerve growth factor (NOF)-stimulated PC12 cells 
[11,18]. In the present study, we examin~.l whether sim- 
ilar MAP kinase activators are also involved in the 
activation mechanism of MAP kinases by ang II in 
cultured VSMC. 
2. MATERIALS AND METHODS 
2.1. Materials 
VSMC were isolated from rat thoracic aorta by enzymatic dissocia- 
tion, as described [19]. ang 11, phorbol 12-myristate 13-acetate (PMA) 
and myelin basic protein (MBP) were purghas~ from Sigma (St. 
Louis, MO, USA), [7-J2P]ATP (3,009 Ci/mmol) was from Amersham 
Japan (Tokyo, Japan). Mous~ monoelonal nti-MAP kiaa,~ antibody 
and goat anti-mouse lgG conjugated with pgroxidase were from 
Zymed Laboratories (San Francisco, CA, USA) and Capp¢l fWest 
Chester, PA, USA), re~l'a~etiv¢ly. Other materials and chemicals were 
obtained h'om commercial sources. 
2.2. Pr,,paration of inactive IdA P kinases 
Unstimalated VSMC (20 × 100-ram dishes) were scraped into buffer 
A containing 20 mM Tris-Cl, pH 7.5, 2 mM EGTA, 1 mM sodium 
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orthovanadate, 10 mM fl-glycerophosphate, I inM dithiothreitol 
(DTT), 1 ,uM APMSF and 100 kallikrein-inactivating U/ml of aprot- 
lain, sonicated and centrifuged as described [17]. Supernatants were 
applied to a DEAE-cellulose column (0.9 × 1.6 gin) pr¢-¢quilibrated 
with buffer A. The column was washed with 5 ml of bulTer A contain- 
in8 20 mM NaCl and the elution was performed with 5 ml of baiter 
A containing 250 mM Natl. The eluate was diluted with 9 vols. of 
baiter A, passed through a 0.22-,urn Millex-GV filter and applied to 
a Mona Q HRS/5 column pre-equilibrated with buffer A. After the 
column was washed with 10 ml of buffer A, the elation was performed 
with a (,'0-ml linear gradient of 0-400 mM blaCl in the same buffer at 
a flow rate of 0.5 ml/min. Fractions of 0.625 ml each were collected 
into tubes. Each fraction (10/.d) was analyzed by immunoblottinswith 
anti-MAP kinas¢ antibody and fractions containing immunoreaetive 
MAP kinascs were used as the inactive MAP kinase preparation. 
2.3. Partial purification of MAP kluase activators 
Extract supernatants prepared from ang ll-stimulated VSMC (20 
× 100-ram dishes) [i7] were passed through a0.22-/,tin MilIex-GV filter 
and applied to a Mona Q HES/5 column pre-equilibrated with buffer 
A. The column was washed and the elution was performed as de- 
scribed above. Each fraction was assayed for MAP kinase activator 
activiD'. Active fractions were applied to a Superose 12 HRI0/30 
column pre-equilibrated with buffer B containing 20 mM Tris.Cl, pH 
7.5, 2 mM EGTA, 1 mM sodium orthovanadate, 50mM p-glycero- 
phosphate, 1 mM DTT, 100 mM NaCI, I /.tM APMSF and 100 
kallikrein-inactivatinB U/ml of aprotinin. The elution was performed 
with buffer B at a flow rate of 0.5 ml/min and fractions of 0.5 ml each 
were collected. Each fraction was assayed for MAP kinase activator 
activity. Active fractions were collected and used as the MAP kinase 
activator. 
2.4. Assay for MAP kinase activator activity 
Column fractions (10 pl) were incubated with 10/al of the inactive 
MAP kinas¢ preparation at 30=C for 15 rain in a final volume of 50 
/zl ¢ontainin8 50 mM ~-[~lyeerophosphate, pH 7,5, 1 mM DTT, 1.5 
mM EGTA, 10 mM magnesium acetate, 40/aM [7-r'P]ATP (2.5 × 10 s 
epm/nmol). After the addition of 10/.d of MBP (0.25 mffml), the 
incubation was continued for a farther 15 min. The reaction was 
terminated by the addition of i ml of ice-cold 20% trichloroacetie acid 
and 60 mM sodium pyrophosphate, and the precipitates were collected 
on a nitrocellulose membrane filter. The filter was washed four times 
with the same solution and the radioactivity was counted using a liquid 
scintillation counter. 
2.5. Phosphorylatlon of MAP kinax'es durbig the incubation with MAP 
kinase activator 
The inactive MAP kinase preparation (10,ul) was incubated at 30=C 
for 15 rain with the MAP kinas¢ activator (10/~1). The reaction mixture 
was the same as that used for the MAP kinas¢ activator assay except 
that the specific activity of [TJ2P]ATP was increased (7.5 × 10 ~ cprrd 
nmol). The reaction was lerminated by the addition of 25 pl of SDS 
sample buffer [20]. The samples were subjected to SDS.PAGE (8-16% 
gel) followed by autoradiography. For phosphoamino acid analysis, 
separated proteins were electrophoretieally transferred to a PVDF 
membrane followed by immunoblotting with the anti-MAP kinase 
antibody, lmmunoreactive bands w,'r¢ excised and subjected to 
pho~phoamino acid analysis accordin8 to the method of Hildebrandt 
and Fried [21] with slisht modifications [17]. 
2.6. Other i~aethods 
The kinase assay in polyacrylamide g ls containing MBP was per- 
formed according to the method of Kameshita nd Fujisawa [22] with 
slight modifications [17]. lmmunoblot analysis with the anti-MAP 
kinase antibody was performed ~ described previo~tsly [17]. 
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Fig. 1. Mona Q HR5/5 column chromatography of ang I[.~timulated or unstimulatcd MAP kinase activity and anti-MAP kina~ immunoblot of 
Mona Q fractions. (A) Cytosolic extracts of VSMC treated for 2 min with 100 nM ang 11 (o) or its vehicle (e) were ~ubj~ted to DEAE--eeIIulos¢ 
column chromatography followed by Mona Q HRS/5 column ehromatosraphy. Aliquots of each fraction were assayed for MAP kinase a~tivity. 
(---) 1NaCl concentration; (1) Kinas¢ 1, (2) Kinas¢ 2. (B) Indicated fractions derived from the unstimulated VSMC were subjected to SDS-PAGE 
lbllowed by immunoblottinB with the anti-MAP kina~ antibody. 
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3. RESULTS 
We have previously described that in VSMC ang 1I 
stimulates activation of two MAP kinases, 40-kDa Ki- 
nase 1 and 45-kDa Kinase 2 [17]. These MAP kinases 
can be separated by Mono Q HRS/5 anion-exchange 
column chromatography; first and second peaks corre- 
spond to Kinase 1 and Kinase 2, respectively (Fig. I A) 
[17]. When the extracts of unstimulated VSMC were 
fractionated by the same Mono Q column, MAP kinase 
activity was hardly detected (Fig. 1A). lmmunoblotting 
of each fraction of unstimulated VSMC extracts with 
the anti-MAP kinase antibody revealed that inactive 
Kinase 1 and Kinase 2 were eluted almost ogether in 
the fractions from number 38 to 43. These fractions 
were collected and used as the inactive MAP kinase 
preparation i the following experiments. 
The inactive MAP kinase preparation was incubated 
with each Mono Q fraction of ang II-stimulated VSMC 
extracts, and MAP kinase activity was assayed. As 
shown in Fig. 2, three peaks of the activities which 
activate the inactive MAP kinase(s) appeared just be- 
fore two peaks of endogenous MAP kinases. These 
MAP kinase activator activities were not detected in 
Mono Q fractions derived from unstimulated VSMC 
(data not shown). Almost identical elution profiles of 
three peaks of MAP kinase activator activities and two 
peaks of MAP kinase activities were obtained when 
extracts of PMA-stimulated VSMC were fractionated 
by the Mono Q column (data not shown). Each peak of 
MAP kinase activator activity was further purified by 
gel filtration chromatography using a Superose 12 
HR10/30 column. Each MAP kinase activator activity 
was elated at almost the same position of molecular 
mass around 60 kDa. In the following in vitro experi- 
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Fig. 2. Mono Q HRS/5 column chromatography ol'ang li-stimulated 
MAP kinase activator activity. Cell exlraets prepared from ang It- 
stimulated VSMC were applied to a Mono Q HRS/5 column. Each 
fraction was incubated with (e) or without (o) the inactive MAP 
kinase preparation and MAP kinase activity was assayed. Arrows 
indicate the MAP kinase activators, (i) Kinase I, (2) Kinase 2. 
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FiB. 3. The kinase assay in a polyacrylamide gel (12%) containing 
MBP. The inactive MAP kinase preparation was incubated with the 
MAP kinase activator for 15 rain, As controls, the inactive MAP 
kinase preparation orthe MAP kinase activator was 5elyaratcly incu- 
bated. Samples were subjected to the kinase assay in polyacrylamide 
gel containing MBP 02% gel), Authentic MAP kina.~s were l~tniaily 
purified from ang It-stimulated VSMC and subjected to the same 
assay. (Lane 1) Inactive MAP kina~ preparation; (lane 2) MAP ki- 
nase activator; (lane 3) inactive MAP kinase preparation and MAP 
kinase activator; (lane 4) partially purified Kinase I; (lane 5) partially 
purified Kinase 2. Arrows indicate the positions o£ MAP kinases. 
ments, we used, as the MAP kinase activator, a prepara- 
tion thus purified from the second peak of MAP kinase 
activator activity on Mono Q column chromatography. 
Similar results were obtained when preparations puri- 
fied from the first or third peaks were used as the MAP 
kinase activator. 
The inactive MAP kinase preparation was incubated 
with the MAP kinase activator and subjected to the 
kinase assay in polyaerylamide g ls containing MBP 
(Fig. 3). MAP kinase activity was detected in two poi- 
ypeptides with apparent molecular masses of 40 and 45 
kDa, which migrated to the identical positions with the 
authentic Kinase 1 and Kinase 2, respectively, indicat- 
ing that both Kinase 1 and Kinase 2 were activated by 
the MAP kinase activator. The activation of MAP ki- 
nases by the MAP kinase activator was dependent on 
the presence of ATP during the incubation period (data 
not shown). No MAP kinase activity was detected when 
the inactive MAP kinase preparation or the MAP ki- 
nase activator was separately incubated. 
When the inactive MAP kinase preparation was incu- 
bated with the MAP kinase activator in the presence of 
[7-3-~P]ATP, two polypeptides with apparent molecular 
masses of 40 and 45 kDa became phosphorylated (Fig. 
4). Immunoblot analysis revealed that these two radio- 
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Fig. 4. Effect of the MAP kinme activator on MAP kinase phospho- 
rylation, The inactive MAP kinase preparation was incubated with the 
MAP kinase activator in the presence of 40/,tM [~'-~'P]ATP lbr 15 rain 
at 30°C. As controls, the inactive MAP kinasc preparation or the 
MAP kinase activator was separately incubated, The reaction was 
terminated by the addition of SDS sample bulTcr l'ollo~ved by SDS- 
PAGE (12% gel). Separated proteins were electrophoretically trans- 
ferred to a PVDF membrane Ibllowed by autoradiography. (Lane !) 
Inactive MAP kinase preparation; (lane 2) MAP kinase activator; 
(lane 3) inactive MAP kinase preparation and MAP kinase activator. 
Arrows indicate the positions of MAP kinases. 
active bands were recognized by the anti-MAP kinase 
antibody (data not shown), indicating that both Kinase 
1 and Kinase 2 were phosphorylated during the in vitro 
activation by the MAP kinase activator. No 
phosphorylated bands ~vere detected when the inactive 
MAP kinase preparation or the MAP kinase activator 
was separately incubated. The radioactive Kinase 1 and 
Kinase 2 bands were excised and subjected to 
phosphoamino acid analysis (Fig. 5). Kinase 1 and Ki- 
nase 2 phosphorylated in vitro contained phosphoty- 
rosine, phosphothreonine and, to a lesser extent, 
phosphoserine. 
4. DISCUSSION 
The results of' the present study provide the first dem- 
onstration that the MAP kinase activators are involved 
in the activation mechanism o1" MAP kinases by ex- 
traceiiuiar signals whose receptors are coupled to phos- 
pholipase C via the GTP-binding protein, Gp. In a pre- 
ceding report, we have demonstrated that ang I1 acti- 
vates two MAP kinases mainly through the protein ki- 
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FiB. S, Phosphoamino acid arml)'sis of MAP kinases phosphorylated 
after incubation with the MAP kinase activator. The inactive MAP 
kinase preparation was incubated with the MAP kinase activator in 
the presence of 40 yM [y.'~-P]ATP for 15 rain at 30°C. The reaction 
was terminated b~, the addition of SDS sample buffer followed by 
SDS-PAGE. Separated proteins were electrophoretically transferred 
to a PVDF membrane followed b)' immunoblo-.ing with the anti- 
MAP kinase antibody. Immunoreactive bai~ds were excised and sub- 
jected to phosphoamino acid analysis. (Lane 1) Kinase 1; (lane 2) 
Kinase 2. The positions of origin, plaosphotyrosine (P-Tyr), 
phosphotlareonine (P-Thr) and phosphoserine (P-Set) were indicated 
to the right, 
nase C-signalling pathway in VSMC [17]. We also de- 
scribed here that the effect of ang 1I on the MAP kinase 
activators was mimicked by the protein kinase C-acti- 
vating phorbol ester, PMA. It has been shown that the 
MAP kinase activator activity is regulated via the pro- 
tein-serine/threonine phosphorylation reaction [18]. Al- 
though it remains to be clarified whether protein kinase 
C directly phosphorylates the MAP kinase activators, 
it seems likely that protein kinase C plays a role in the 
activation mechanism of the MAP kinase activators by 
aug II. 
The aug ll-stimulated MAP kinase activator activity 
was separated into three peaks on Mono Q anion-ex- 
change column chromatography. They had similar mo- 
lecular masses, as assessed by gel filtration, and similar 
activator activities to each other. Similarly, two peaks 
of M~P kinasc activator ~ ": :': - " " ,~c,v,,,es o ,  the same ,at..-" '"'~ 
exchange column chromatography were described in 
EGF-stimulated fibroblasts and NGF-stimulated PCI2 
cells [1 1,18]. Although the relationship between these 
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peaks of the MAP kinas¢ activators remains to be clar- 
ified, they may represent multiple isoforms of the MAP 
kinase activators. 
Although the molecular mechanism by which the 
MAP kinase activators induce tyrosine and serine/thre- 
onine phosphorylation f MAP kinases has not yet been 
clarified, some possibilities have been proposed. Sin~ 
MAP kinases undergo autophosphorylation on both 
tyrosine and serine/threonine residues, the possibility is 
proposed that the MAP kinase activators function by 
enhancing the ability of MAP kinases to undergo auto- 
phosphorylation [23-25]. Anothor possibility is that the 
MAP kinase activators are protein kinases with specific- 
ity for either tyrosine or serine/threonine; either type of 
phosphorylation by the MAP kinase activators en- 
hances another type of autophosphorylation of MAP 
kinases. However, recent observations obtained using 
the kinase-defective or autophosphorylation site-defec- 
tive mutants of MAP kinases raise the possibility that 
the MAP kinase activators are protein kinases capable 
of phosphorylating both tyrosine and serine/threonine 
residues of MAP kinases [26,27]. Purification and mo- 
lecular cloning of the MAP kinase activators will clarify 
which of these is the case. 
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